show episodes
 
Welcome to Guts & Glory, hosted by SingHealth Internal Medicine residents Dillon and Ching Han, together with consultant gastroenterologist Dr Andrew Ong! Each episode, we hope to bring you guys the latest in gastroenterology and hepatology approaches, updates, and discussions that you can tune into anytime. Join us, whether you're on your way to pre-round at 5 am, typing your 7th discharge summary of the day, or going home after reviewing your blue letters at 10 pm. This podcast is meant fo ...
 
Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gast ...
 
Vision To Prevent and Cure Liver Disease Mission To advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD was founded in 1950 by a small group of leading liver specialists (including Hans Popper, Leon Schiff, Fred Hoffbauer, Cecil Watson, Jesse Bollman, and Sheila Sherlock, to name a few) to bring t ...
 
Specialty Stories is a podcast to help premed and medical students choose a career. What would you do if you started your career and realized that it wasn't what you expected? Specialty Stories will talk to physicians and residency program directors from every specialty to help you make the most informed decision possible. Check out our others shows at MededMedia.com
 
Loading …
show series
 
On this episode of Liver Talks, Alex and Adam are joined by Dr. Nadim Mahmud of the University of Pennsylvania to discuss his training and career, surgical risk stratification in cirrhosis--notably the creation of his group's VOCAL-Penn score--and tips for getting involved in Big Data. VOCAL-Penn Instrument: https://www.vocalpennscore.com/ Risk Pre…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Harish Gagnejam MD What are some ways we can strike the perfect balance when it comes to treating our patients with GERD? To help us answer this question, Dr. Harish Gagneja from the Dell Medical School at the University of Texas joins Dr. Peter Buch to explore balanced treatment options for these patie…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Brennan Spiegel, MD, MSHS Let’s escape our busy day for a moment to imagine the future of gastroenterology and to ask ourselves: How can technology make us better clinicians? Explore that very question with Drs. Peter Buch and Brennan Spiegel as they discuss the latest advances in artificial intelligenc…
 
In our first international episode, Dr. Peter Lu and Dr. Temara Hajjat cross the Atlantic (virtually) to talk to the illustrious Dr. Marc Benninga from Emma Children's Hospital/Academic Medical Centre in Amsterdam, the Netherlands. Dr. Benninga is not only our first guest from our sister society ESPGHAN, but also the first Olympian and perhaps the …
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexander Perelman, D.O. Small intestinal bacterial overgrowth (SIBO) has been recognized for years, yet the optimal method of diagnosis remains controversial. So to help clear up the controversy, Dr. Peter Buch welcomes back returning guest Dr. Alexander Perelman to talk about diagnosing and treating S…
 
What is hepatobiliary sepsis? Joining us this episode, is Dr Ong Wai Choung, Senior Consultant Gastroenterologist from Singapore General Hospital, who specializes in interventional endoscopy on top of general gastroenterology. Dr Ong discusses the general approaches to patients who present with hepatobiliary sepsis - the clinical presentation, rele…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Adam S. Cheifetz, MD Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine…
 
Would you rather be on bleeder call for an entire month, or run 10 back to back clinic sessions in a week? Be scoped by a hepatologist, or have a liver biopsy by an endoscopist? Take a break from the grind and join us in this special episode, where we speak with 4 of our very own Gastroenterology Senior Residents. Hear about their lives as senior r…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Asma Khapra, MD Over the last few years, we've only started to gain an understanding of how gender affects our approach to GI illnesses. And since a greater awareness of these differences will help us become better clinicians, Dr. Peter Buch speaks with Dr. Asma Khapra about how we can optimize our appr…
 
Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas. Read the full article: The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas…
 
Drs. Temara Hajjat and Peter Lu talk to Dr. Marla Dubinsky, a professor of pediatrics and a pediatric gastroenterologist at Mount Sinai Hospital. We discuss the approach to fertility and pregnancy in IBD. Learning Objectives 1) To identify IBD medications that are safe during pregnancy and lactation 2) To learn the impact of IBD disease activity in…
 
Drs. Jennifer Lee and Jason Silverman talk to Dr. Maria Mascarenhas, a pediatric gastroenterologist and the director of the integrative health program at Children's Hospital of Philadelphia. We discuss how extra training in integrative medicine has helped Dr. Mascarenhas take her clinical practice to the next level. We ask how training in culinary …
 
Host: Neilanjan Nandi, MD Guest: Peter D. Higgins, MDm PhD What's on the horizon for the management of inflammatory bowel disease? To share some of the latest clinical trial updates, Dr. Neil Nandi is joined by Dr. Peter Higgins from the University of Michigan to explore some of the latest developments in early detection tools and treatment strateg…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Michael L. Weinstein, MD As clinicians, providing the best quality of care is paramount. But when it comes to procedure-intensive specialties, medical malpractice is a notable concern. So what do we need to know about the common malpractice claims in the GI field, and how can we mitigate the risk of tho…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Alexander Perelman, D.O. Proton pump inhibitors (PPIs) are among the most frequently prescribed medications in the world, but in many instances, they may be unnecessary. So how might this impact our patients’ health, and how can we identify those patients who should be prescribed PPIs? Dr. Peter Buch is…
 
Join us in the second episode of this 2-part series on GERD! Dr Andrew Ong discusses with the help of 3 case studies, the non-pharmacological and pharmacological approach to treating patients with Gastroesophageal Reflux Disease, through targeting the various symptom triggers and symptom modulators.By Dillon, Ching Han, Andrew
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hetal A. Karsan, MD, FACG, FAASLD, FASGE, FACP Primary biliary cholangitis, which was formerly known as primary biliary cirrhosis, is a chronic disease that progresses over time. Fortunately, much progress has been made in that many patients are being diagnosed and treated much earlier than before. But …
 
In this collaborative episode with JPGN, Drs. Peter Lu and Jason Silverman talk to Dr. Jim Squires, the first author of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure published recently in JPGN. Although this is a complex syndrome a…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Lea Ann Chen, MD As clinicians, we know that adherence to treatment regimens is associated with improved outcomes in our patients with inflammatory bowel disease (IBD). However, many factors can contribute to a patient's nonadherence, and understanding what those factors are, especially in underserved p…
 
Join us in this 2 part series, as our very own host, Dr Andrew Ong, goes through his approach to patients with symptoms suggestive of gastroesophageal reflux disease (GERD). Using 3 case studies, we discuss the definitions of GERD, and delve into understanding what are some of the symptom triggers and symptom modulators behind GERD.…
 
Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators. Read the full article: Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling studyBy The Lancet Gastroenterology & Hepatology
 
Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Rakesh Kalapala, Senior Consultant Gastroenterologist & Therapeutic Endoscopist, Head of GI Motility Lab, Director of Endoscopy at the Center for Obesity & Metabolic Therapy, Member of the International…
 
In this episode of Bowel Sounds, hosts Drs. Jennifer Lee and Peter Lu talk to Dr. Hayat Mousa about the most severe of gastrointestinal motility disorders -- pediatric intestinal pseudo-obstruction or PIPO. Although PIPO is a rare disorder, it is one that is important for all pediatric gastroenterologists to recognize. Dr. Mousa is Director of the …
 
Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection. Read the full article: A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Erick Argueta, MD Since only 70 percent of initial eradication attempts of Helicobacter pylori are successful, it’s important for us to understand the factors that might be contributing to this startling statistic. That’s why Dr. Peter Buch speaks with Dr. Erick Argueta about why Helicobacter pylori can…
 
Viral hepatitis affects millions of people around the world, with disproportionate impact in certain countries around the globe. Around 3.6% of Singapore's population are hepatitis B carriers, although many go about their lives unaware of this. Viral hepatitis screens, are commonly sent off for various indications - abnormal liver function tests, w…
 
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin L. Cohen, MD Inflammatory bowel disease (IBD) among the elderly is common, and when compared to IBD in younger patients, it’s characterized by a different disease course and has an increased risk of mortality. So how can we achieve better outcomes for our elderly patients? Dr. Peter Buch is joi…
 
In this episode of Bowel Sounds, hosts Drs. Temara Hajjat and Peter Lu talk to Dr. Judith Kelsen about the presentation, evaluation, and management of children with very early onset inflammatory bowel disease (VEO-IBD). Learning Objectives 1) To define and describe the clinical presentation of very early onset IBD 2) To examine diagnostic strategie…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login